View in EDS

Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.

Saved in:
Bibliographic Details
Title: Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.
Authors: Kang CS; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Kim DH; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Department of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea., Lim H; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Kim S; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Almaslamani M; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Kang CM; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea., Woo SK; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.; Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.
Source: Molecular pharmaceutics [Mol Pharm] 2025 Jul 07; Vol. 22 (7), pp. 3793-3802. Date of Electronic Publication: 2025 May 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1543-8392
DOI:10.1021/acs.molpharmaceut.5c00043